Jwb. Moll et al., SYSTEMIC AND ANTINEURONAL AUTOANTIBODIES IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISEASE, Journal of neurology, 243(1), 1996, pp. 51-56
Sera from 23 patients with paraneoplastic disease of the central nervo
us system (PNS) were examined for the presence of anti-neuronal (anti-
Hu, anti-Yo/PCA) and anti-Ri) and systemic auto-antibodies, including
antibodies against DNA, centromeres, nRNP, Sm antigen, Scl-70, Ro(SS-A
), La(SS-B), mitochondria, thyroid antigens, parietal calls, brush bor
der antigen and rheumatoid factor. As controls, sera from 33 patients
with small cell lung cancer, 33 with ovarian cancer and 7 with breast
cancer and from 107 aged-matched healthy persons were used. Systemic a
uto-antibodies were found in 52% of patients with paraneoplastic neuro
logical syndromes compared with only 16% (P = 0.001) in the control gr
oup with cancer only and 15% in the group of healthy controls. The rel
atively high percentage of systemic auto-antibodies in patients with P
NS indicates that there is a genetic susceptibility to the development
of auto-immune phenomena. This may provide an explanation fur the rel
atively rare occurrence of PNS in patients with cancer.